Glypican 3 抗体 (AA 201-300) (AbBy Fluor® 488)
Quick Overview for Glypican 3 抗体 (AA 201-300) (AbBy Fluor® 488) (ABIN899203)
抗原
See all Glypican 3 (GPC3) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 201-300
-
交叉反应
- 人, 小鼠
-
预测反应
- Rat
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human glypican 3
-
亚型
- IgG
-
-
-
-
应用备注
- FCM 1:20-100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- Glypican 3 (GPC3)
-
别名
- glypican 3
-
背景
-
Synonyms: glypican 3, glypican3, glypican-3, GPC3, Intestinal protein OCI-5, GTR2-2, MXR7.Intestinal protein OCI-5.
Background: Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome. (Also known as glypican 3, Intestinal protein OCI-5, GTR2-2, MXR7, Glypican-3 precursor).
-
基因ID
- 2719
-
途径
- Glycosaminoglycan Metabolic Process
抗原
-